Malignant Melanoma
Showing 51 - 75 of 202
Malignant Melanoma Trial in Amsterdam (Tilsotolimod, Saline (0.9% sodium chloride))
Recruiting
- Malignant Melanoma
- Tilsotolimod
- Saline (0.9% sodium chloride)
-
Amsterdam, NetherlandsVU Medical Centere
Apr 14, 2021
Malignant Melanoma Trial in United States (BMS-936558 (MDX1106-04), Ipilimumab)
Completed
- Malignant Melanoma
- BMS-936558 (MDX1106-04)
- Ipilimumab
-
New Haven, Connecticut
- +3 more
Mar 19, 2021
Malignant Melanoma Trial in Gothenburg (Neurofilament light protein measurement in Isolated limb perfused patients)
Completed
- Malignant Melanoma
- Neurofilament light protein measurement in Isolated limb perfused patients
-
Gothenburg, SwedenSahlgrenska University Hospital
Mar 16, 2021
Malignant Melanoma Trial in Germany (Encorafenib, Binimetinib, Pembrolizumab)
Completed
- Malignant Melanoma
- Encorafenib
- +3 more
-
Freiburg, Baden-Württemberg, Germany
- +10 more
Feb 13, 2021
Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)
Completed
- Melanoma
- +4 more
- therapeutic conventional surgery
- +3 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center
Dec 30, 2020
IL-2 "SELECT" Tissue Collection Protocol in Advanced Melanoma
Completed
- Malignant Melanoma
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 13, 2021
Malignant Melanoma Trial in Shanghai (Camrelizumab for injection)
Recruiting
- Malignant Melanoma
- Camrelizumab for injection
-
Shanghai, Shanghai, China
- +1 more
Dec 20, 2020
Activity of Immune Checkpoint Inhibitor Therapy in Advanced
Recruiting
- Malignant Melanoma
-
Jette, Brabant, Belgium
- +1 more
Dec 16, 2020
Suction Drain in Axillary Lymph Node Dissection for Malignant
Completed
- Malignant Melanoma
-
Graz, Styria, AustriaMedical University of Graz
Nov 23, 2020
NSCLC, Urothelial Carcinoma, Malignant Melanoma Trial in Aurora, Lake Mary, Philadelphia (CAN04, Pembrolizumab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- +3 more
-
Aurora, Colorado
- +2 more
Nov 17, 2020
Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)
Completed
- Malignant Melanoma
- Recurrent Melanoma
- Dacarbazine
- +2 more
- (no location specified)
Oct 18, 2020
Malignant Melanoma, Nevus, Pigmented, Basal Cell Carcinoma Trial in Copenhagen (optical coherence tomography)
Unknown status
- Malignant Melanoma
- +3 more
- optical coherence tomography
-
Copenhagen, DenmarkDept of Dermatology
Nov 2, 2020
Malignant Melanoma Trial in New York (Imiquimod, NY-ESO-1 protein)
Completed
- Malignant Melanoma
- Imiquimod
- NY-ESO-1 protein
-
New York, New YorkNYU Cancer Institute
Sep 28, 2020
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
Advanced Ovarian Cancer, Malignant Melanoma Trial in Toronto (drug, procedure, biological)
Completed
- Advanced Ovarian Cancer
- Malignant Melanoma
- Cyclophosphamide
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Aug 12, 2020
Malignant Melanoma Trial in Tampa (HyperAcute-Melanoma Vaccine)
Completed
- Malignant Melanoma
- HyperAcute-Melanoma Vaccine
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
May 26, 2020
Malignant Melanoma, Adjuvant Drug Therapy, Vaccin Therapy Trial in Meldola (FC), Meldola (Autologous Dendritic Cell vaccine)
Terminated
- Malignant Melanoma
- +2 more
- Autologous Dendritic Cell vaccine
-
Meldola (FC), FC, Italy
- +1 more
Apr 20, 2020